Atlas Venture Fund VII L P 13D/13G Filings for Larimar Therapeutics, Inc. (LRMR)

Atlas Venture Fund VII L P 13D and 13G filings for Larimar Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-02
1:04 pm
Purchase		 2020-12-31 13G Larimar Therapeutics, Inc.
LRMR		 Atlas Venture Fund VII L P 292,182
1.900%		 292,182increase
(New Position)		 Filing